Informational Meeting: The Importation of Infectious Biological Agents, Infectious Substances and Vectors; Public Webcast, 43812 [2019-18100]
Download as PDF
<![CDATA[
43812
Federal Register / Vol. 84, No. 163 / Thursday, August 22, 2019 / Notices
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Form name
PHQ–9 .............................................................................................................
FIBSER ............................................................................................................
Clinician Survey ...............................................................................................
Total .................................................................................................................
Total
burden hours
150
200
15
365
Average
hourly
wage rate
22.5
20
1.25
42.5
Total
cost burden
* $24.98
* 24.98
# 39.42
24.98
$562.05
499.6
49.28
1,110.93
* Based on the mean wages for all occupations, 00–0000. May 2018 National Occupational Employment and Wage Estimates. U.S. Department of Labor, Bureau of Labor Statistics. Available at: https://www.bls.gov/oes/current/oes_nat.htm#00-0000.
# Based on the mean wages for Healthcare Practitioners and Technical Occupations, 29–0000. May 2018 National Occupational Employment
and Wage Estimates. U.S. Department of Labor, Bureau of Labor Statistics. Available at: https://www.bls.gov/oes/current/oes_nat.htm#29-0000.
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ’s health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: August 19, 2019.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2019–18113 Filed 8–21–19; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Informational Meeting: The Importation
of Infectious Biological Agents,
Infectious Substances and Vectors;
Public Webcast
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of public webcast.
AGENCY:
SUMMARY: The Centers for Disease
Control and Prevention (CDC),
VerDate Sep<11>2014
16:37 Aug 21, 2019
Jkt 247001
Department of Health and Human
Services (HHS), is hosting a public
webcast to address import permit
regulations for infectious biological
agents, infectious substances, and
vectors. Besides CDC, presenters for this
webcast may include representatives
from the U.S. Department of
Transportation, U.S. Department of
Agriculture, Department of Homeland
Security, and U.S. National Authority
for Containment (NAC) of Polioviruses.
DATES: The webcast will be held on
December 4, 2019, from 11 a.m. to 4
p.m. (EST). Registration instructions are
found on the HHS/CDC Import Permit
Program website, https://www.cdc.gov/
cpr/ipp/index.htm.
ADDRESSES: The webcast will be
broadcast from the Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT:
Samuel S. Edwin, Director, Division of
Select Agents and Toxins, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H–21–7,
Atlanta, Georgia 30329. Telephone:
(404) 718–2000.
SUPPLEMENTARY INFORMATION: This
webcast is an opportunity for all
interested parties (e.g., academic
institutions; biomedical centers;
commercial manufacturing facilities;
federal, state, and local laboratories,
including clinical and diagnostic
laboratories; research facilities;
exhibition facilities; and educational
facilities) to obtain specific guidance
and information regarding import
permit regulations for the importation of
infectious biological agents, infectious
substances and vectors. The webcast
will also provide assistance to those
interested in applying for an import
permit from federal agencies within the
United States. Instructions for
registration are found on the HHS/CDC
Import Permit Program website, https://
www.cdc.gov/cpr/ipp/index.htm.
Participants must register by
November 22, 2019. This is a webcastonly event and there will be no on-site
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
participation at the HHS/CDC broadcast
facility.
Dated: August 19, 2019.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2019–18100 Filed 8–21–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–P–0076]
Determination That ZONEGRAN
(Zonisamide) Capsules, 50 Milligrams,
Was Not Withdrawn From Sale for
Reasons of Safety or Effectiveness
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA or Agency) has
determined that ZONEGRAN
(zonisamide) capsules, 50 milligrams
(mg), was not withdrawn from sale for
reasons of safety or effectiveness. This
determination means that FDA will not
begin procedures to withdraw approval
of abbreviated new drug applications
(ANDAs) that refer to this drug product,
and it will allow FDA to continue to
approve ANDAs that refer to the
product as long as they meet relevant
legal and regulatory requirements.
FOR FURTHER INFORMATION CONTACT:
Daniel Gottlieb, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6210,
Silver Spring, MD 20993–0002, 301–
796–6650, Daniel.Gottlieb@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In 1984,
Congress enacted the Drug Price
Competition and Patent Term
Restoration Act of 1984 (Pub. L. 98–417)
(the 1984 amendments), which
authorized the approval of duplicate
versions of drug products under an
E:\FR\FM\22AUN1.SGM
22AUN1
]]>Agencies
[Federal Register Volume 84, Number 163 (Thursday, August 22, 2019)]
[Notices]
[Page 43812]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18100]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Informational Meeting: The Importation of Infectious Biological
Agents, Infectious Substances and Vectors; Public Webcast
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of public webcast.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC),
Department of Health and Human Services (HHS), is hosting a public
webcast to address import permit regulations for infectious biological
agents, infectious substances, and vectors. Besides CDC, presenters for
this webcast may include representatives from the U.S. Department of
Transportation, U.S. Department of Agriculture, Department of Homeland
Security, and U.S. National Authority for Containment (NAC) of
Polioviruses.
DATES: The webcast will be held on December 4, 2019, from 11 a.m. to 4
p.m. (EST). Registration instructions are found on the HHS/CDC Import
Permit Program website, https://www.cdc.gov/cpr/ipp/index.htm.
ADDRESSES: The webcast will be broadcast from the Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT: Samuel S. Edwin, Director, Division of
Select Agents and Toxins, Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop H-21-7, Atlanta, Georgia 30329.
Telephone: (404) 718-2000.
SUPPLEMENTARY INFORMATION: This webcast is an opportunity for all
interested parties (e.g., academic institutions; biomedical centers;
commercial manufacturing facilities; federal, state, and local
laboratories, including clinical and diagnostic laboratories; research
facilities; exhibition facilities; and educational facilities) to
obtain specific guidance and information regarding import permit
regulations for the importation of infectious biological agents,
infectious substances and vectors. The webcast will also provide
assistance to those interested in applying for an import permit from
federal agencies within the United States. Instructions for
registration are found on the HHS/CDC Import Permit Program website,
https://www.cdc.gov/cpr/ipp/index.htm.
Participants must register by November 22, 2019. This is a webcast-
only event and there will be no on-site participation at the HHS/CDC
broadcast facility.
Dated: August 19, 2019.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2019-18100 Filed 8-21-19; 8:45 am]
BILLING CODE 4163-18-P
